A randomised controlled trial of cannabidiol for the treatment of cannabis use disorder: A study protocol

被引：0

作者：

Lintzeris, Nicholas ^{[1
,2
]}

Bhardwaj, Anjali ^{[1
,2
]}

Lubman, Dan I. ^{[3
]}

Doyle, Michael ^{[2
]}

Dunlop, Adrian J. ^{[4
]}

Mills, Llewellyn ^{[2
]}

Harrod, Mary E. ^{[5
]}

Arunogiri, Shalini ^{[3
]}

Malouf, Peter ^{[6
]}

Haber, Paul S. ^{[2
,7
]}

Freeman, Tomp. ^{[8
]}

Montebello, Mark E. ^{[2
,9
]}

Graham, Robert ^{[10
]}

Childs, Steven ^{[11
]}

Monds, Lauren A. ^{[2
,9
]}

Jeffries, Meryem ^{[10
]}

Nean, Martin ^{[4
]}

Ella, Stephen ^{[12
]}

机构：

[1] South East Sydney Local Hlth Dist, Drug & Alcohol Serv, Sydney, NSW, Australia

[2] Univ Sydney, Fac Med, Sydney, NSW, Australia

[3] Ctr Addict & Mental Hlth, Turning Point, Melbourne, Vic, Australia

[4] Hunter New England Local Hlth Dist, Drug & Alcohol Clin Serv, Newcastle, NSW, Australia

[5] NSW Users & AIDS Assoc, Sydney, NSW, Australia

[6] Townsville Aboriginal & Torres Strait Islander Co, Townsville, Qld, Australia

[7] Sydney Local Hlth Dist, Drug Hlth Serv, Sydney, NSW, Australia

[8] Univ Bath, Addict & Mental Hlth Grp, Bath, Avon, England

[9] North Sydney Local Hlth Dist, Drug & Alcohol Serv, Sydney, NSW, Australia

[10] Western Sydney Local Hlth Dist, Drug Hlth, Sydney, NSW, Australia

[11] Cent Coast Local Hlth Dist, Drug & Alcohol Serv, Gosford, Australia

[12] Cent Coast Local Hlth Dist, Nunyara Aboriginal Hlth, Gosford, Australia

来源：

DRUG AND ALCOHOL REVIEW | 2023年 / 42卷

基金：

英国医学研究理事会;

关键词：

D O I：

暂无

中图分类号：

R194 [卫生标准、卫生检查、医药管理];

学科分类号：

摘要：

373

引用

页码：S109 / S109

页数：1

共 50 条

[1] A phase III multisite randomised controlled trial to compare the efficacy of cannabidiol to placebo in the treatment of cannabis use disorder: the CBD-CUD study protocol
Anjali K. Bhardwaj
Llew Mills
Michael Doyle
Arshman Sahid
Mark Montebello
Lauren Monds
Shalini Arunogiri
Paul Haber
Valentina Lorenzetti
Dan I. Lubman
Peter Malouf
Mary E. Harrod
Adrian Dunlop
Tom Freeman
Nicholas Lintzeris
[J]. BMC Psychiatry, 24
[2] A phase III multisite randomised controlled trial to compare the efficacy of cannabidiol to placebo in the treatment of cannabis use disorder: the CBD-CUD study protocol
Bhardwaj, Anjali K.
Mills, Llew
Doyle, Michael
Sahid, Arshman
Montebello, Mark
Monds, Lauren
Arunogiri, Shalini
Haber, Paul
Lorenzetti, Valentina
Lubman, Dan I.
Malouf, Peter
Harrod, Mary E.
Dunlop, Adrian
Freeman, Tom
Lintzeris, Nicholas
[J]. BMC PSYCHIATRY, 2024, 24 (01)
[3] Effects of cannabidiol on anandamide levels in individuals with cannabis use disorder: findings from a randomised clinical trial for the treatment of cannabis use disorder
Daniel Ying-Heng Hua
Chandni Hindocha
Gianluca Baio
Rachel Lees
Natacha Shaban
Celia J. Morgan
Ali Mofeez
H. Valerie Curran
Tom P. Freeman
[J]. Translational Psychiatry, 13
[4] Effects of cannabidiol on anandamide levels in individuals with cannabis use disorder: findings from a randomised clinical trial for the treatment of cannabis use disorder
Hua, Daniel Ying-Heng
Hindocha, Chandni
Baio, Gianluca
Lees, Rachel
Shaban, Natacha
Morgan, Celia J. J.
Mofeez, Ali
Curran, H. Valerie
Freeman, Tom P. P.
[J]. TRANSLATIONAL PSYCHIATRY, 2023, 13 (01)
[5] Cannabidiol for the treatment of cannabis use disorder: a phase 2a, double-blind, placebo-controlled, randomised, adaptive Bayesian trial
Freeman, Tom P.
Hindocha, Chandni
Baio, Gianluca
Shaban, Natacha D. C.
Thomas, Emily M.
Astbury, Danica
Freeman, Abigail M.
Lees, Rachel
Craft, Sam
Morrison, Paul D.
Bloomfield, Michael A. P.
O'Ryan, Dominic
Kinghorn, Jane
Morgan, Celia J. A.
Mofeez, Ali
Curran, H. Valerie
[J]. LANCET PSYCHIATRY, 2020, 7 (10): : 865 - 874
[6] Cannabidiol versus risperidone for treatment of recent-onset psychosis with comorbid cannabis use: study protocol for a randomized controlled clinical trial
Rasmussen, Jesper Ostrup
Jennum, Poul
Linnet, Kristian
Glenthoj, Birte Y.
Baandrup, Lone
[J]. BMC PSYCHIATRY, 2021, 21 (01)
[7] Cannabidiol versus risperidone for treatment of recent-onset psychosis with comorbid cannabis use: study protocol for a randomized controlled clinical trial
Jesper Østrup Rasmussen
Poul Jennum
Kristian Linnet
Birte Y. Glenthøj
Lone Baandrup
[J]. BMC Psychiatry, 21
[8] Correlates of treatment engagement and client outcomes: results of a randomised controlled trial of nabiximols for the treatment of cannabis use disorder
Mills, Llewellyn
Dunlop, Adrian
Montebello, Mark
Copeland, Jan
Bruno, Raimondo
Jefferies, Meryem
Mcgregor, Iain
Lintzeris, Nicholas
[J]. SUBSTANCE ABUSE TREATMENT PREVENTION AND POLICY, 2022, 17 (01)
[9] Correlates of treatment engagement and client outcomes: results of a randomised controlled trial of nabiximols for the treatment of cannabis use disorder
Llewellyn Mills
Adrian Dunlop
Mark Montebello
Jan Copeland
Raimondo Bruno
Meryem Jefferies
Iain Mcgregor
Nicholas Lintzeris
[J]. Substance Abuse Treatment, Prevention, and Policy, 17
[10] The neurobehavioural effects of cannabidiol in alcohol use disorder: Study protocol for a double-blind, randomised, cross over, placebo-controlled trial
Hurzeler, Tristan P.
Logge, Warren
Watt, Joshua
DeMayo, Marilena M.
Suraev, Anastasia
McGregor, Iain S.
Haber, Paul S.
Morley, Kirsten C.
[J]. CONTEMPORARY CLINICAL TRIALS COMMUNICATIONS, 2024, 41

← 1 2 3 4 5 →